Firm type · Focus area

Drug Discovery Venture Debt Providers

The RaiseHunt database lists 104 Drug Discovery venture debt providers: all of them list a portfolio, 921 known investments between them and 482 people at those firms have a profile here. That is the overlap between 3,626 venture debt providers and 1,313 Drug Discovery investment firms. Most list Late-Stage and Growth among the rounds they take part in; the largest concentrations are in New York, Boston and London.

Part of venture debt providers and Drug Discovery investment firms.

Strongest in New York, Boston and London

Backing rounds at Late-Stage and Growth

104: Investment firms
104: With a known portfolio
921: Known investments
482: People with a profile

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

104 Drug Discovery venture debt providers

Showing 101-104

Filters

Viewing

Venture debt3,626 Drug Discovery1,313

Firm type1

See all 10→

Investment stage

Choosing one replaces Drug Discovery.

See all 6→

Sector

Choosing one replaces Drug Discovery.

See all 14→

Focus area1

See all 365→

Firm	Location	Type	Markets	Actions
SP Straus Partners		Venture debt	Healthcare	View fund
TY Teng Yue Partners	New York, United States	Private equityVenture debt	Healthcare	View fund
AC Allele Capital Partners	Fort Lauderdale, United States	Private equityVenture debt	Healthcare	View fund
Aurelia Partners	Stockholm, Sweden	Venture debt	FinTechHealthcare	View fund

Data: RaiseHunt investor dataset · Snapshot 16 October 2026 · How this data is built · Report a correction or request removal